Literature DB >> 22287287

What is the evidence for radical surgery in the management of localized embryonal bladder/prostate rhabdomyosarcoma?

Nicholas Alexander1, Sheila Lane, Rowena Hitchcock.   

Abstract

As survival outcomes for bladder/prostate rhabdomyosarcoma have improved over the last 40 years, the emphasis has shifted to minimizing treatment related morbidity. We undertook a critical review of the current literature to examine the role of radical pelvic surgery to achieve local control. We illustrate that there appears to be no difference in overall survival or event free survival when comparing differing modalities utilized in local disease control, microscopic disease clearance does not correlate with improved outcomes, and the morbidity associated with radical surgery for BP RMS is significantly greater than for a conservative method of local control.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22287287     DOI: 10.1002/pbc.24087

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  5 in total

1.  Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.

Authors:  David A Rodeberg; Moody D Wharam; Elizabeth R Lyden; Julie A Stoner; Kenneth Brown; Suzanne L Wolden; Charles N Paidas; Sarah S Donaldson; Douglas S Hawkins; Sheri L Spunt; Carola A Arndt
Journal:  Int J Cancer       Date:  2014-12-10       Impact factor: 7.396

2.  Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children's Oncology Group.

Authors:  Lillian Sung; Richard Aplenc; Todd A Alonzo; Robert B Gerbing; Thomas Lehrnbecher; Alan S Gamis
Journal:  Blood       Date:  2013-03-07       Impact factor: 22.113

3.  Optimal surgical treatment and urological outcomes in boys with pelvic and urogenital rhabdomyosarcomas and soft tissue sarcomas.

Authors:  Tomoro Hishiki; Takeshi Saito; Tetsuya Mitsunaga; Mitsuyuki Nakata; Elena Terui; Shugo Komatsu; Naoko Mise; Kazuaki Harada; Jun Iwai; Yasuyuki Higashimoto; Yuri Okimoto; Harumi Kakuda; Hidemasa Ochiai; Moeko Hino; Sumie Homma; Yuichi Osa; Hideo Yoshida
Journal:  Pediatr Surg Int       Date:  2013-10       Impact factor: 1.827

4.  Appraisal of the role of radical prostatectomy for rhabdomyosarcoma in children: oncological and urological outcome.

Authors:  Lorenzo Angelini; Gianni Bisogno; Ciro Esposito; Marco Castagnetti
Journal:  Ther Adv Urol       Date:  2018-03-07

5.  Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children's Oncology Group.

Authors:  Timothy B Lautz; Yueh-Yun Chi; Minjie Li; Suzanne L Wolden; Dana L Casey; Jonathan C Routh; Candace F Granberg; Odion Binite; Erin R Rudzinski; Douglas S Hawkins; Rajkumar Venkatramani; David A Rodeberg
Journal:  Cancer       Date:  2020-10-20       Impact factor: 6.921

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.